ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,064 | -20.3% | 1,354,541 | -0.6% | 0.01% | 0.0% |
| Q2 2023 | $5,099 | +109.1% | 1,363,382 | +87.4% | 0.01% | +133.3% |
| Q1 2023 | $2,438 | -18.3% | 727,700 | +17.3% | 0.00% | -25.0% |
| Q4 2022 | $2,985 | -99.9% | 620,600 | +3.9% | 0.00% | -20.0% |
| Q3 2022 | $3,399,000 | -27.8% | 597,400 | -9.9% | 0.01% | -16.7% |
| Q2 2022 | $4,707,000 | -44.0% | 663,000 | -43.1% | 0.01% | -40.0% |
| Q1 2022 | $8,411,000 | +51.5% | 1,165,000 | +87.7% | 0.01% | +42.9% |
| Q4 2021 | $5,550,000 | +600.8% | 620,800 | +2646.9% | 0.01% | +600.0% |
| Q3 2021 | $792,000 | – | 22,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |